67.47
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
Dexcom Stock Finds Its Range: What The Latest Drift, Data, And Deals Signal For 2026 - AD HOC NEWS
FDA says Dexcom issues correction for Dexcom G6 and G6 Pro software - marketscreener.com
E. Ohman J or Asset Management AB Raises Position in DexCom, Inc. $DXCM - Defense World
SWS Partners Purchases 19,073 Shares of DexCom, Inc. $DXCM - MarketBeat
Beacon Investment Advisory Services Inc. Trims Stock Position in DexCom, Inc. $DXCM - Defense World
Class Action Alert: Levi & Korsinsky Reminds DexCom (DXCM) Investors of December 26, 2025 Deadline - ACCESS Newswire
DexCom, Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
DexCom, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before December 26, 2025 to Discuss Your RightsDXCM - Finviz
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, - GlobeNewswire
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm - GlobeNewswire Inc.
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Levi & Korsinsky Urges DexCom (DXCM) Shareholders to Act Before Lead Plaintiff Deadline December 26, 2025 - ACCESS Newswire
Lost Money on DexCom, Inc. (DXCM)? Join Class Action Before December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
December 26, 2025 Deadline: Join Class Action Lawsuit Against DexCom, Inc. (DXCM)Contact Levi & Korsinsky - ACCESS Newswire
Securities Lawsuit Alert: DexCom, Inc. (DXCM) InvestorsContact Levi & Korsinsky Before December 26, 2025 - ACCESS Newswire
DAVENPORT & Co LLC Increases Position in DexCom, Inc. $DXCM - MarketBeat
Lost Money on DexCom, Inc. (DXCM)? Urged to Join Class Action Before December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
DXCM ALERT: Securities Fraud Class Action Launched Against DexCom, Inc.December 26, 2025 Deadline - ACCESS Newswire
Investor Alert: Deadline Approaching to Join DexCom, Inc. (DXCM) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Class Action Lawsuit Filed: DexCom, Inc. (DXCM)Join by December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
Voya Investment Management LLC Sells 186,132,582 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom (DXCM): Reassessing Valuation After Class Action Lawsuits and New FDA Clearance for Smart Basal - Sahm
An Intrinsic Calculation For DexCom, Inc. (NASDAQ:DXCM) Suggests It's 47% Undervalued - 富途牛牛
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
DexCom, Inc. (DXCM) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of December 26, 2025 Deadline - Stockhouse
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc.(DXCM) Shareholders - The Malaysian Reserve
Tune Into the SueWallSt Podcast: DexCom, Inc. (DXCM) Lawsuit Explained - ACCESS Newswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DexCom, Inc. $DXCM Shares Sold by Congress Asset Management Co. - MarketBeat
Dexcom G6 Continuous Glucose Monitoring (CGM) Lawsuit - Drugwatch.com
Class Action Filed Against DexCom, Inc. (DXCM) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
DexCom, Inc. (DXCM) Announces Leadership Transition with New CEO Appointment - GuruFocus
Dexcom Names Jacob Leach as Incoming Chief Executive - TipRanks
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DexCom Inc Announces CEO Appointment - TradingView — Track All Markets
Shareholders SueWallSt in New Class Action Against DexCom, Inc.Act Now - Nasdaq
2025-12-22 | Lost Money on DexCom, Inc. (DXCM)? Urged to Join Class Action Before December 26, 2025Contact Levi & Korsinsky | NDAQ:DXCM | Press Release - Stockhouse
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Morgan Stanley Upgrades DexCom (DXCM), Cites Undervalued Recovery and G7 Margin Potential - Insider Monkey
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
10 Best Growth Stocks to Buy in 2026 - Insider Monkey
What sentiment indicators say about DexCom Inc. stockQuarterly Profit Review & AI Enhanced Trading Signals - Улправда
December 26, 2025 Deadline Approaching: Join Class Action Against DexCom, Inc. (DXCM)Contact Levi & Korsinsky - Stockhouse
Important December 26, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Investors of Securities Fraud Class Action Lawsuit - The Malaysian Reserve
Zevenbergen Capital Investments LLC Purchases 62,098 Shares of DexCom, Inc. $DXCM - MarketBeat
Is DexCom Inc. stock supported by strong cash flowsJuly 2025 Trends & Smart Money Movement Tracker - Улправда
Investors SueWallSt as DexCom, Inc. Faces Securities Fraud Allegations - Nasdaq
Will DexCom Inc. stock sustain high P E ratios2025 Key Lessons & Reliable Entry Point Trade Alerts - Улправда
DXCM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will DexCom Inc. stock benefit from sector rotationJuly 2025 Snapshot & Low Drawdown Trading Techniques - DonanımHaber
Dexcom (DXCM) Gets a Buy from Canaccord Genuity - The Globe and Mail
Investors who lost money on DexCom, Inc. (DXCM) should contact Levi & Korsinsky about pending Class ActionDXCM - Sahm
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):